Aptima Neisseria gonorrhoeae Assay
Dna-Reagents, Neisseria. 510(k) K231329, from Hologic, Inc. (San Diego, CA). Product code LSL, class 2.
As of Nov 21, 2026, K231329 is an FDA 510(k) held by Hologic, Inc., substantially equivalent on Jan 26, 2024 after 263 days, with no recalls tied to it in FDA's recall database.
- Review time: 263 days
- Recalls: 0
The Aptima Neisseria gonorrhoeae (GC) Assay is an in vitro qualitative nucleic acid amplification (NAAT) test for the detection of ribosomal RNA (rRNA) from Neisseria gonorrhoeae (GC) to aid in the diagnosis of gonococcal urogenital disease using the Panther System. The assay may be used to test male urine specimens from symptomatic and asymptomatic individuals.
- Gen-Probe Aptima Assay for Neisseria Gonorrhoeae Model#1091K063664 · Gen-Probe, Inc. · Jan 25, 2007
- Gen-Probe Aptima Assay for Neisseria GonorrhoeaeK043144 · Gen-Probe, Inc. · Mar 14, 2005
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 8, 2023
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files